These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38596556)

  • 21. A case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiency.
    Park GT; Jeon DW; Roh KH; Mun HS; Lee CH; Park CH; Kang KW; Kim SM; Kang JM; Park HC
    Korean J Intern Med; 1999 Jan; 14(1):85-7. PubMed ID: 10063319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
    Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
    Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate-induced pancytopenia: a case series of 46 patients.
    Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
    Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Case Report on Iatrogenic Methotrexate Toxicity.
    Quan Soon KL; Shah S; Ibrahim R; Alzwahereh K
    Cureus; 2024 Jul; 16(7):e64081. PubMed ID: 39114248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful multiple-exchange peritoneal dialysis in a patient with severe hematological toxicity by methotrexate: case report and literature review.
    Aristizabal-Alzate A; Nieto-Rios JF; Ocampo-Kohn C; Serna-Higuita LM; Bello-Marquez DC; Zuluaga-Valencia GA
    J Bras Nefrol; 2019; 41(3):427-432. PubMed ID: 30281061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
    Calvo-Romero JM
    Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose methotrexate-induced fulminant hepatic failure and pancytopenia in an acute lymphoblastic leukaemia paediatric patient.
    Sajith M; Pawar A; Bafna V; Bartakke S
    Eur J Hosp Pharm; 2020 May; 27(3):178-180. PubMed ID: 32419940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate-induced Severe Pancytopenia in a Patient with Rheumatoid Arthritis: A Case Report and Review of Literature.
    Hosseini E; Shahbazi F
    Curr Drug Saf; 2024; 19(2):224-235. PubMed ID: 37194235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical dilemma over low-dose methotrexate therapy in dialysis patients: a case report and review of literature.
    Liu WC; Chen HC; Chen JS
    Iran J Kidney Dis; 2014 Jan; 8(1):81-4. PubMed ID: 24413728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-Dose Methotrexate Toxicity Presenting as Pancytopenia.
    Dhillon GS; Chauhan S; Jalal Y; Ghobrial Y; Ahmed B
    Cureus; 2022 Dec; 14(12):e32494. PubMed ID: 36654616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate-Induced Cutaneous Ulcers: A Rare Side Effect.
    Bahnson AB; Sturm T
    S D Med; 2021 Jul; 74(7):304-305. PubMed ID: 34449990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancytopenia after low dose methotrexate therapy in a hemodialysis patient: case report and review of literature.
    Yang CP; Kuo MC; Guh JY; Chen HC
    Ren Fail; 2006; 28(1):95-7. PubMed ID: 16526326
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Tamura S; Koyama A; Yamashita Y; Shiotani C; Nakamoto H; Nakamoto C; Suzuki M; Nakano Y; Imaoka K; Sonoki T; Fujimoto T
    IDCases; 2017; 10():18-21. PubMed ID: 28831382
    [No Abstract]   [Full Text] [Related]  

  • 34. Shingles: More than Meets the Eye.
    Komitova RT; Grklanov VA; Lindas KK; Ganeva PV
    Folia Med (Plovdiv); 2019 Mar; 61(1):158-162. PubMed ID: 31237855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis.
    Cornelissen JJ; Bakker LJ; Van der Veen MJ; Rozenberg-Arska M; Bijlsma JW
    Ann Rheum Dis; 1991 Sep; 50(9):642-4. PubMed ID: 1929588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?
    Vincent S; Slease RB; Rocca PV
    Del Med J; 2002 Dec; 74(12):469-73. PubMed ID: 15595320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serious complications during treatment with methotrexate: also in chronic low-dosage use].
    Rodenburg RJ; Wijnands MJ; Rensma PL
    Ned Tijdschr Geneeskd; 2017; 161():D575. PubMed ID: 28120731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate-induced cutaneous ulcers in a nonpsoriatic patient: case report and review of the literature.
    Kurian A; Haber R
    J Cutan Med Surg; 2011; 15(5):275-9. PubMed ID: 21962187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate Cutaneous Toxicity following a Single Dose of 10 mg in a Case of Chronic Plaque Psoriasis: A Possible Idiosyncratic Reaction.
    Gupta A; Sardana K; Bhardwaj M; Singh A
    Indian Dermatol Online J; 2018; 9(5):328-330. PubMed ID: 30258802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute mucocutaneous methotrexate toxicity with marked tissue eosinophilia.
    Borda LJ; Ross A; Villada G; Milikowski C
    BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29627775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.